Enovix (NASDAQ:ENVX) Releases Q1 2025 Earnings Guidance

Enovix (NASDAQ:ENVX) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of -0.210–0.150 for the period, compared to the consensus estimate of -0.170. The company issued revenue guidance of $3.5 million-$5.5 million, compared to the consensus revenue estimate of $6.2 million.

Enovix Stock Performance

ENVX traded up $0.03 during trading hours on Wednesday, hitting $11.19. The stock had a trading volume of 10,623,974 shares, compared to its average volume of 6,858,173. The company’s fifty day simple moving average is $11.03 and its 200 day simple moving average is $10.29. Enovix has a 1 year low of $5.70 and a 1 year high of $18.68. The stock has a market cap of $1.99 billion, a PE ratio of -6.95 and a beta of 1.87. The company has a quick ratio of 3.61, a current ratio of 3.77 and a debt-to-equity ratio of 0.99.

Enovix (NASDAQ:ENVX) last posted its quarterly earnings data on Wednesday, February 19th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.01. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. Equities analysts anticipate that Enovix will post -1.16 earnings per share for the current year.

Wall Street Analyst Weigh In

ENVX has been the subject of several research analyst reports. JPMorgan Chase & Co. dropped their price objective on Enovix from $18.00 to $15.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Janney Montgomery Scott lowered Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target for the company. in a research note on Thursday, October 31st. Benchmark reaffirmed a “buy” rating and set a $25.00 price target on shares of Enovix in a research note on Wednesday, October 30th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $30.00 price target on shares of Enovix in a research note on Wednesday, October 30th. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Enovix currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.50.

Insider Transactions at Enovix

In other news, Director Betsy S. Atkins sold 75,000 shares of Enovix stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total value of $729,750.00. Following the transaction, the director now owns 99,497 shares in the company, valued at approximately $968,105.81. The trade was a 42.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 15.70% of the company’s stock.

About Enovix

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.